The Burden of Stress Urinary Incontinence

Slides:



Advertisements
Similar presentations
Perimenopausal migraine in women with vasomotor symptoms E. Anne MacGregor Maturitas Volume 71, Issue 1, Pages (January 2012) DOI: /j.maturitas
Advertisements

The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
Medical Management for BPH: The Role of Combination Therapy
Pascal Rischmann  European Urology Supplements 
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Volume 49, Issue 2, Pages (February 2006)
Female Urinary Incontinence in the West of Turkey: Prevalence, Risk Factors and Impact on Quality of Life  Izzet Kocak, Pinar Okyay, Mehmet Dundar, Haluk.
Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management  Michael O’Leary  European Urology Supplements 
Management of Acute and Chronic Retention in Men
Volume 49, Issue 2, Pages (February 2006)
Debra E. Irwin, Ian Milsom, Zoe Kopp, Paul Abrams  European Urology 
Volume 64, Issue 4, Pages (October 2013)
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
John P. Mulhall, Francesco Montorsi  European Urology 
Martin C. Michel  European Urology Supplements 
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Volume 50, Issue 4, Pages (October 2006)
Back to the Future: Introduction and Conclusions
Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH)  Raymond C. Rosen, Francois Giuliano, Culley.
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
A Novel Treatment of Premature Ejaculation
Treatment of Symptomatic Benign Prostatic Hyperplasia: Current and Future Clinical Practice in Europe – What is Really Happening?  Bob Djavan  European.
Counselling the Prostate Cancer Patient
A priori probabilities in Y23 mixture analysis: Non-contributor experiments using simulated powerplex® Y23 Y-STR mixtures  D. Moore, T. Clayton, J. Thomson 
Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old  P. Perrin,
An Update of Current Practice in Hypospadias Surgery
Treatment of Bacterial Urinary Tract Infections: Presence and Future
Richard C. Harkaway  European Urology Supplements 
Volume 51, Issue 1, Pages (January 2007)
Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy  Bertrand Tombal, Richard Berges  European Urology.
Ian Milsom  European Urology Supplements 
Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH):
Antonio Alcaraz, Pierre Teillac  European Urology Supplements 
Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice  Claus Roehrborn  European Urology.
Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH):
Challenges and Opportunities in Hormone-Resistant Prostate Cancer
Pharmacotherapy in Stress and Mixed Incontinence
What are the Data on 5α-Reductase Inhibitor Treatment of Benign Prostatic Hyperplasia from Everyday Practice?  François Desgrandchamps  European Urology.
Christian Stief  European Urology Supplements 
European Urology is “Your” Journal
Volume 65, Issue 6, Pages (June 2014)
Emmanuel Chartier-Kastler, Kate Davidson  European Urology Supplements 
A Cross-Sectional, Population-Based, Multinational Study of the Prevalence of Overactive Bladder and Lower Urinary Tract Symptoms: Results from the EPIC.
Reevaluating the Health-Related Quality of Life Impact and the Economic Burden of Urgency Urinary Incontinence  Anastasios Athanasopoulos, Salvador Arlandis.
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Martin Michel, Jean de la Rosette  European Urology Supplements 
Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer  P. Mongiat-Artus, P. Teillac 
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
The European Online Sexual Survey (EOSS): Pan-European Perspectives on the Impact of Premature Ejaculation and Treatment-Seeking Behavior  John Dean 
Profile of Silodosin European Urology Supplements
New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men
Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study  Bob Djavan,
Testim® Gel: Review of Clinical Data
Cardiovascular Safety of Tamsulosin Modified Release in the Fasted and Fed State in Elderly Healthy Subjects  Martin C. Michel, Cees Korstanje, Walter.
C.G Roehrborn, T McNicholas  European Urology Supplements 
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Joaquim Bellmunt  European Urology Supplements 
Classification of Mixed Incontinence
Economic and Social Impact of OAB
The Impact of Premature Ejaculation on Partners and Relationships
Emmanuel Chartier-Kastler, Andrea Tubaro  European Urology Supplements 
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?  Mark J. Speakman  European Urology Supplements 
Integrating Patient Risk Profiles in the Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) in Clinical Practice 
Jan Roigas  European Urology Supplements 
Volume 51, Issue 5, Pages (May 2007)
Michael Marberger  European Urology Supplements 
Appropriate Castration with Luteinising Hormone Releasing Hormone (LHRH) Agonists: What is the Optimal Level of Testosterone?  B. Tombal  European Urology.
Presentation transcript:

The Burden of Stress Urinary Incontinence Gunnar Lose  European Urology Supplements  Volume 4, Issue 1, Pages 5-10 (January 2005) DOI: 10.1016/j.eursup.2004.10.002 Copyright © 2004 Elsevier B.V. Terms and Conditions

Fig. 1 Distribution of the various types of UI in Europe and the US [4,5]. European Urology Supplements 2005 4, 5-10DOI: (10.1016/j.eursup.2004.10.002) Copyright © 2004 Elsevier B.V. Terms and Conditions

Fig. 2 Self-reported impact of SUI among women who are moderately to extremely bothered. Respondents rated how much of a negative impact urinary leakage had on each of the items, using a scale of 1 to 5 [21]. European Urology Supplements 2005 4, 5-10DOI: (10.1016/j.eursup.2004.10.002) Copyright © 2004 Elsevier B.V. Terms and Conditions

Fig. 3 Burden of UI in treatment seekers vs. non-seekers. Self-reported bothersomeness rated on a scale of not or slightly bothered to moderately and extremely bothered; Self-reported symptom severity rated on a scale from mild to moderate and severe. * Treatment seekers vs. non-seekers: p<0.01 [5]. European Urology Supplements 2005 4, 5-10DOI: (10.1016/j.eursup.2004.10.002) Copyright © 2004 Elsevier B.V. Terms and Conditions

Fig. 4 Self-coping strategies of women with UI: bothered versus not-bothered women [28]. European Urology Supplements 2005 4, 5-10DOI: (10.1016/j.eursup.2004.10.002) Copyright © 2004 Elsevier B.V. Terms and Conditions